Skip to main content
VCbacked
Log inGet Started

Upfront Diagnostics

Cambridge, United Kingdom

Upfront Diagnostics is discovering biomarkers to improve medical diagnosis.

$4.3M raised
May 2025
Venture - Series Unknown
Health CareHealth Diagnostics

Top Investors

Creator FundCambridge Enterprise VenturesStroke AssociationPHOENIX SUSTAINABLE INVESTMENTS LIMITEDSBRI Healthcare

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Upfront Diagnostics

How much funding has Upfront Diagnostics raised?
Upfront Diagnostics has raised $4.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
Who are Upfront Diagnostics's investors?
Upfront Diagnostics's investors include Creator Fund, Cambridge Enterprise Ventures, Stroke Association, PHOENIX SUSTAINABLE INVESTMENTS LIMITED, SBRI Healthcare.
Where is Upfront Diagnostics headquartered?
Upfront Diagnostics is headquartered in Cambridge, United Kingdom.
What does Upfront Diagnostics do?
Upfront Diagnostics is discovering biomarkers to improve medical diagnosis.
What stage is Upfront Diagnostics at?
Upfront Diagnostics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Upfront Diagnostics — Funding & Investors." VCBacked, May 12, 2025, https://www.vcbacked.co/company/upfront-diagnostics. Accessed June 4, 2026.
APA
VCBacked. (2025). Upfront Diagnostics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/upfront-diagnostics
Wikipedia (cite web)
{{cite web |title=Upfront Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/upfront-diagnostics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K